Literature DB >> 16651450

Menin links estrogen receptor activation to histone H3K4 trimethylation.

Koen M A Dreijerink1, Klaas W Mulder, G Sebastiaan Winkler, Jo W M Höppener, Cornelis J M Lips, H Th Marc Timmers.   

Abstract

The product of the multiple endocrine neoplasia type 1 (MEN1) tumor suppressor gene, menin, is an integral component of MLL1/MLL2 histone methyltransferase complexes specific for Lys4 of histone H3 (H3K4). We show that menin is a transcriptional coactivator of the nuclear receptors for estrogen and vitamin D. Activation of the endogenous estrogen-responsive TFF1 (pS2) gene results in promoter recruitment of menin and in elevated trimethylation of H3K4. Knockdown of menin reduces both activated TFF1 (pS2) transcription and H3K4 trimethylation. In addition, menin can directly interact with the estrogen receptor-alpha (ERalpha) in a hormone-dependent manner. The majority of disease-related MEN1 mutations prevent menin-ERalpha interaction. Importantly, ERalpha-interacting mutants are also defective in coactivator function. Our results indicate that menin is a critical link between recruitment of histone methyltransferase complexes and nuclear receptor-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651450     DOI: 10.1158/0008-5472.CAN-05-4461

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  86 in total

1.  miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.

Authors:  Laurent Ehrlich; Chad Hall; Julie Venter; David Dostal; Francesca Bernuzzi; Pietro Invernizzi; Fanyin Meng; Jerome P Trzeciakowski; Tianhao Zhou; Holly Standeford; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Am J Pathol       Date:  2017-01-11       Impact factor: 4.307

2.  Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.

Authors:  Imran Hussain; Arunoday Bhan; Khairul I Ansari; Paromita Deb; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-02-25

3.  Chromatin signature of embryonic pluripotency is established during genome activation.

Authors:  Nadine L Vastenhouw; Yong Zhang; Ian G Woods; Farhad Imam; Aviv Regev; X Shirley Liu; John Rinn; Alexander F Schier
Journal:  Nature       Date:  2010-03-24       Impact factor: 49.962

Review 4.  Intersection of nuclear receptors and the proteasome on the epigenetic landscape.

Authors:  H Karimi Kinyamu; Wendy N Jefferson; Trevor K Archer
Journal:  Environ Mol Mutagen       Date:  2008-01       Impact factor: 3.216

5.  Aberrant histone modifications at the thyrotropin-releasing hormone gene in resistance to thyroid hormone: analysis of F455S mutant thyroid hormone receptor.

Authors:  Ryohei Umezawa; Masanobu Yamada; Kazuhiko Horiguchi; Sumiyasu Ishii; Koshi Hashimoto; Shuichi Okada; Teturou Satoh; Masatomo Mori
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

6.  Menin represses tumorigenesis via repressing cell proliferation.

Authors:  Ting Wu; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-05-16       Impact factor: 6.166

Review 7.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

8.  Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.

Authors:  Ping La; Yuqing Yang; Satyajit K Karnik; Albert C Silva; Robert W Schnepp; Seung K Kim; Xianxin Hua
Journal:  J Biol Chem       Date:  2007-08-31       Impact factor: 5.157

Review 9.  Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.

Authors:  Xinjiang Wu; Xianxin Hua
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

10.  Breast-cancer predisposition in multiple endocrine neoplasia type 1.

Authors:  Koen M A Dreijerink; Pierre Goudet; John R Burgess; Gerlof D Valk
Journal:  N Engl J Med       Date:  2014-08-07       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.